• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性手术后宫颈腺癌和鳞状细胞癌的结局模式:队列研究倾向评分匹配分析前后

Outcome patterns of cervical adenocarcinoma and squamous cell carcinoma following curative surgery: before and after propensity score matching analysis of a cohort study.

作者信息

Zhang Jiaqiang, Qin Lei, Chen Ho-Min, Hsu Han-Chuan, Chuang Chih-Chi, Chen Dar, Wu Szu-Yuan

机构信息

Department of Anesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University Zhengzhou, Henan, China.

School of Statistics, University of International Business and Economics Beijing, China.

出版信息

Am J Cancer Res. 2020 Jun 1;10(6):1793-1807. eCollection 2020.

PMID:32642291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7339276/
Abstract

To estimate the outcome patterns and predictors of curative surgery for cervical squamous cell carcinoma (SCC) and adenocarcinoma (ADC) for overall survival (OS), locoregional recurrence (LRR), and distant metastasis (DM), we enrolled 4628 patients who had received a diagnosis of cervical SCC or ADC and received curative surgery. Cox regression analysis was employed to calculate hazard ratios and confidence intervals (CIs); independent predictors were controlled for or stratified in the analysis, and the endpoint was all-cause death. Propensity score matching was conducted to create well-balanced groups. Multivariate Cox regression analysis indicated that the pathologic type of ADC, age ≥ 70 years, advanced pathologic stage, positive margin, poorly differentiated cancer, undifferentiated cancer, adjuvant sequential chemotherapy and radiotherapy, earlier year of diagnosis, Charlson comorbidity index (CCI) = 1, CCI ≥ 2, low income levels, and treatment at a nonmedical center were significant independent poor prognostic factors for all-cause mortality in cervical cancer treated with curative surgery. Adjusted hazard ratios (95% CIs) for patients with cervical ADC who received curative surgery were 2.34 (1.96-2.79), 1.15 (0.89-1.49), and 2.16 (1.75-2.66) compared with cervical SCC for all-cause mortality, LRR, and DM, respectively. This study indicated that curative surgery for cervical ADC was associated with poorer OS and higher DM rates relative to cervical SCC, but no significant differences were identified in LRR.

摘要

为了评估宫颈鳞状细胞癌(SCC)和腺癌(ADC)根治性手术后的生存结局模式及总生存(OS)、局部区域复发(LRR)和远处转移(DM)的预测因素,我们纳入了4628例经诊断为宫颈SCC或ADC并接受了根治性手术的患者。采用Cox回归分析计算风险比和置信区间(CI);在分析中对独立预测因素进行控制或分层,终点为全因死亡。进行倾向评分匹配以创建均衡组。多因素Cox回归分析表明,ADC的病理类型、年龄≥70岁、病理分期晚期、切缘阳性、低分化癌、未分化癌、辅助序贯化疗和放疗、诊断年份较早、Charlson合并症指数(CCI)=1、CCI≥2、低收入水平以及在非医疗中心接受治疗是接受根治性手术的宫颈癌患者全因死亡的显著独立不良预后因素。接受根治性手术的宫颈ADC患者相对于宫颈SCC患者,全因死亡、LRR和DM的调整后风险比(95%CI)分别为2.34(1.96 - 2.79)、1.15(0.89 - 1.49)和2.16(1.75 - 2.66)。本研究表明,相对于宫颈SCC,宫颈ADC根治性手术的OS较差且DM率较高,但在LRR方面未发现显著差异。

相似文献

1
Outcome patterns of cervical adenocarcinoma and squamous cell carcinoma following curative surgery: before and after propensity score matching analysis of a cohort study.根治性手术后宫颈腺癌和鳞状细胞癌的结局模式:队列研究倾向评分匹配分析前后
Am J Cancer Res. 2020 Jun 1;10(6):1793-1807. eCollection 2020.
2
Overall survival, locoregional recurrence, and distant metastasis of definitive concurrent chemoradiotherapy for cervical squamous cell carcinoma and adenocarcinoma: before and after propensity score matching analysis of a cohort study.宫颈鳞状细胞癌和腺癌同期放化疗的总生存期、局部区域复发及远处转移:队列研究倾向评分匹配分析前后情况
Am J Cancer Res. 2020 Jun 1;10(6):1808-1820. eCollection 2020.
3
Does adenocarcinoma have a worse prognosis than squamous cell carcinoma in patients with cervical cancer? A real-world study with a propensity score matching analysis.腺癌在宫颈癌患者中的预后是否比鳞癌差?一项基于倾向评分匹配分析的真实世界研究。
J Gynecol Oncol. 2020 Nov;31(6):e80. doi: 10.3802/jgo.2020.31.e80.
4
Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.子宫颈鳞状细胞癌和腺癌中环氧合酶-2的差异表达。
Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):822-9. doi: 10.1016/j.ijrobp.2004.04.030.
5
Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.组织学对宫颈鳞状细胞癌、腺癌和小细胞神经内分泌癌患者的预后影响。
Asian Pac J Cancer Prev. 2013;14(9):5355-60. doi: 10.7314/apjcp.2013.14.9.5355.
6
Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.与鳞状细胞癌相比,宫颈腺癌的预后较差,远处复发倾向更高。
Int J Gynecol Cancer. 2017 Jul;27(6):1228-1236. doi: 10.1097/IGC.0000000000001009.
7
The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study.早期宫颈癌组织学类型的预后意义——一项多机构研究。
Gynecol Oncol. 2015 Jun;137(3):474-8. doi: 10.1016/j.ygyno.2015.02.005. Epub 2015 Feb 10.
8
Outcome of post-mastectomy radiotherapy after primary systemic treatment in patients with different clinical tumor and nodal stages of breast cancer: a cohort study.不同临床肿瘤和淋巴结分期乳腺癌患者接受初次全身治疗后乳房切除术后放疗的结果:一项队列研究
Am J Cancer Res. 2020 Jul 1;10(7):2185-2198. eCollection 2020.
9
Adjuvant Radiotherapy Is Associated with an Increase in the Survival of Old (Aged over 80 Years) and Very Old (Aged over 90 Years) Women with Breast Cancer Receiving Breast-Conserving Surgery.辅助放疗与接受保乳手术的老年(80岁以上)和高龄(90岁以上)乳腺癌女性生存率的提高相关。
J Pers Med. 2022 Feb 16;12(2):287. doi: 10.3390/jpm12020287.
10
Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.单中心研究:不同组织学类型局部晚期宫颈癌的治疗结局:倾向评分匹配研究。
J Formos Med Assoc. 2018 Oct;117(10):922-931. doi: 10.1016/j.jfma.2018.07.002. Epub 2018 Jul 17.

引用本文的文献

1
Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era.放疗前PET-CT对宫颈癌的生存影响:图像引导调强放疗时代
Front Oncol. 2023 Jan 31;13:1012491. doi: 10.3389/fonc.2023.1012491. eCollection 2023.
2
The Association of Preoperative PET-CT and Survival in Patients with Resectable Cervical Cancer.可切除宫颈癌患者术前PET-CT与生存率的相关性
J Clin Med. 2022 Dec 1;11(23):7143. doi: 10.3390/jcm11237143.
3
Insufficient pain control for patients with cancer and dementia during terminal cancer stages.癌症晚期合并痴呆症患者的疼痛控制不足。
Am J Transl Res. 2021 Nov 15;13(11):13034-13042. eCollection 2021.
4
Contemporary external beam radiotherapy boost or high dose-rate brachytherapy boost for cervical cancer: a propensity-score-matched, nationwide, population-based cohort study.当代宫颈癌体外照射放疗增敏或高剂量率近距离放疗增敏:一项倾向评分匹配的全国性基于人群的队列研究。
Am J Cancer Res. 2021 Apr 15;11(4):1719-1732. eCollection 2021.
5
Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity.新辅助化疗或内分泌治疗用于激素受体高度阳性且人表皮生长因子受体2阴性的乳腺浸润性导管癌
JAMA Netw Open. 2021 Mar 1;4(3):e211785. doi: 10.1001/jamanetworkopen.2021.1785.
6
Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical Cancer.局部和全身STAT3及p65核因子-κB表达作为宫颈癌患者的病情进展标志物和功能靶点
Front Oncol. 2020 Nov 19;10:587132. doi: 10.3389/fonc.2020.587132. eCollection 2020.

本文引用的文献

1
Optimal treatments for cervical adenocarcinoma.宫颈腺癌的最佳治疗方法。
Am J Cancer Res. 2019 Jun 1;9(6):1224-1234. eCollection 2019.
2
Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.年龄增长预示着宫颈癌预后不良,进而影响治疗和总体生存。
Brachytherapy. 2019 Jan-Feb;18(1):29-37. doi: 10.1016/j.brachy.2018.08.016. Epub 2018 Oct 22.
3
Treatment outcomes for unresectable intrahepatic cholangiocarcinoma: Nationwide, population-based, cohort study based on propensity score matching with the Mahalanobis metric.无法切除的肝内胆管癌的治疗结果:基于马氏距离的倾向评分匹配的全国性、基于人群的队列研究。
Radiother Oncol. 2018 Nov;129(2):284-292. doi: 10.1016/j.radonc.2018.09.010. Epub 2018 Sep 29.
4
Intensity-modulated radiotherapy with systemic chemotherapy improves survival in patients with nonmetastatic unresectable pancreatic adenocarcinoma: A propensity score-matched, nationwide, population-based cohort study.强度调制放疗联合全身化疗可改善不可切除局部晚期胰腺癌患者的生存:一项倾向评分匹配的全国性基于人群的队列研究。
Radiother Oncol. 2018 Nov;129(2):326-332. doi: 10.1016/j.radonc.2018.07.012. Epub 2018 Aug 3.
5
Outcomes of adjuvant treatments for resectable intrahepatic cholangiocarcinoma: Chemotherapy alone, sequential chemoradiotherapy, or concurrent chemoradiotherapy.可切除肝内胆管癌辅助治疗的结果:单纯化疗、序贯放化疗或同期放化疗。
Radiother Oncol. 2018 Sep;128(3):575-583. doi: 10.1016/j.radonc.2018.05.011. Epub 2018 May 22.
6
Efficacy of thoracic radiotherapy in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment.接受并对酪氨酸激酶抑制剂治疗有反应的 IIIB-IV 期表皮生长因子受体突变型肺腺癌患者接受胸部放疗的疗效。
Radiother Oncol. 2018 Oct;129(1):52-60. doi: 10.1016/j.radonc.2018.03.007. Epub 2018 Apr 24.
7
Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.可手术宫颈癌术后辅助治疗的预后评估:中国国家癌症中心10年经验
Chin J Cancer Res. 2017 Dec;29(6):510-520. doi: 10.21147/j.issn.1000-9604.2017.06.05.
8
Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study.采用调强放疗的低剂量或高剂量同期放化疗治疗晚期鼻咽癌:一项倾向评分匹配的全国性基于人群的队列研究。
Radiother Oncol. 2018 Oct;129(1):23-29. doi: 10.1016/j.radonc.2017.12.004. Epub 2017 Dec 22.
9
Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.基于剂量递增调强放疗的同步放化疗对晚期胸段食管鳞状细胞癌有效。
Radiother Oncol. 2017 Oct;125(1):73-79. doi: 10.1016/j.radonc.2017.08.025. Epub 2017 Sep 17.
10
Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.胸段食管鳞癌三模态治疗或根治性同步放化疗的价值与应用。
Cancer. 2017 Oct 15;123(20):3904-3915. doi: 10.1002/cncr.30823. Epub 2017 Jun 13.